Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mice does not affect adipogenesis or adipose tissue development

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH05-11-0742
Issue:2006: 95/6 (June) pp. 917-1051
Pages:1019-1024

Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mice does not affect adipogenesis or adipose tissue development

Diego Demeulemeester, Ilse Scroyen, Gabor Voros, Jan Snoeys, Bart De Geest, Désiré Collen, H. Roger Lijnen
Center for Molecular and Vascular Biology, K.U. Leuven, Leuven, Belgium

Summary

In order to evaluate a potential functional role of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in development of obesity, we studied the effect of overexpression of human TIMP-1 (hTIMP-1) in C57Bl/6J mice in vivo and in 3T3-F442A preadipocytes in vitro. Stable long-term overexpression of hTIMP-1 in mice was achieved by adenoviral gene transfer, yielding plasma levels exceeding 250 ng/ml at eight weeks after injection. Mice overexpressing hTIMP-1 and kept on a high fat diet for 14 weeks had body weights, adipose tissue weights, and adipocyte diameters that were somewhat, but not significantly, lower than those of control mice. Similar observations were made after overexpression of hTIMP-1 in mice with lipectomy of the subcutaneous adipose tissue, kept on a high fat diet for 20 weeks.In both in vivo models,blood vessels in the adipose tissues were significantly smaller after hTIMP-1 gene transfer than in control mice. Overexpression of hTIMP-1 in 3T3-F442A preadipocytes had no effect on their subsequent differentiation into mature adipocytes.Thus,overexpression of hTIMP-1 in mice had no significant effect on ongoing adipogenesis or adipose tissue development, although the blood vessel size in adipose tissues was reduced.

Keywords

obesity, adipose tissue, Tissue inhibitor of metalloproteinase-1, TIMP-1, adipogenesis

DOI

http://dx.doi.org/10.1160/TH05-11-0742

You may also be interested in...

1.

Katsutaka Oishi1, Naoki Ohkura2, Juzo Matsuda2, Norio Ishida1,3

Thrombosis and Haemostasis 2007 98 4: 864-870

http://dx.doi.org/10.1160/TH07-04-0268

2.

H. Roger Lijnen 1, Marie-Christine Alessi 2, Liesbeth Frederix 1, Désiré Collen, Irène Juhan-Vague 2

Thrombosis and Haemostasis 2006 96 6: 731-737

http://dx.doi.org/10.1160/TH06-08-0422

3.

Javier Gómez-Ambrosi 1 , Javier Salvador2 , Camilo Silva2 , Carlos Pastor3 , Fernando Rotellar3 , María J. Gil4 , Javier A. Cienfuegos3 , Gema Frühbeck1,2

Thrombosis and Haemostasis 2006 95 6: 991-996

http://dx.doi.org/10.1160/TH06-02-0079



Articles

You've 475 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...